CMS Fact Sheet Aims To Clarify Coverage-With-Evidence-Development Policy
This article was originally published in The Gray Sheet
Executive Summary
CMS' coverage-with-evidence-development (CED) policy mainly will be used to generate data for FDA-approved products that are being used for a different indication, according to the agency